Reuters logo
BRIEF-Bellerophon Therapeutics reports Q3 loss per share $0.22
2017年11月7日 / 下午2点08分 / 16 天前

BRIEF-Bellerophon Therapeutics reports Q3 loss per share $0.22

Nov 7 (Reuters) - Bellerophon Therapeutics Inc

* Bellerophon provides business update and reports third quarter 2017 financial results

* Q3 loss per share $0.22

* Says ‍ phase 2a study for inopulse met its primary endpoint​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below